[The first Russian trial of treating patients with acute nonlymphoblastic leukemias with novantrone combined with cytosar].
Volkova
M A
MA
Kaletin
G I
GI
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D010198:Pancytopenia / Q000139:chemically induced; D012074:Remission Induction; D012426:Russia; D013997:Time Factors
D003561:Cytarabine; D008942:Mitoxantrone
Pervyĭ otechestvennyĭ opyt lecheniia bol'nykh ostrymi nelimfoblastnymi leĭkozami novantronom v sochetanii s tsitozarom.